Back to Dashboard
Unknown

Royalty Pharma Plc

USA Unknown Filing: 2026-03-31
25/100
Smart-money confidence1 of 3 sources positive
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
34
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Who's behind the signal
Every informed buyer we can see on ROYALTY PHARMA PLC, across all three feeds.
Hedge funds · 6
AQR Capital Management Increased +48%
D.E. Shaw & Co Increased +34%
Baillie Gifford & Co Decreased −5%
Tudor Investment (Paul Tudor Jones) Decreased −27%
Citadel Advisors Decreased −49%
Point72 (Steve Cohen) Decreased −8%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. ROYALTY PHARMA PLC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
0
New positions
2
Increasing
4
Decreasing
0
Unchanged
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
AQR Capital Management
Trust weight: 1.0×
Increased +48%
% of portfolio
0.1%
Position change
+48%
0.1% of AQR Capital Management's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Increased +34%
% of portfolio
0.1%
Position change
+34%
0.1% of D.E. Shaw & Co's portfolio
Baillie Gifford & Co
Trust weight: 1.4×
Decreased −5%
% of portfolio
0.8%
Position change
−5%
0.8% of Baillie Gifford & Co's portfolio
Tudor Investment (Paul Tudor Jones)
Trust weight: 1.2×
Decreased −27%
% of portfolio
0.2%
Position change
−27%
0.2% of Tudor Investment's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −49%
% of portfolio
0.1%
Position change
−49%
0.1% of Citadel Advisors's portfolio
Point72 (Steve Cohen)
Trust weight: 1.1×
Decreased −8%
% of portfolio
0.0%
Position change
−8%
0.0% of Point72's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ROYALTY PHARMA PLC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ROYALTY PHARMA PLC or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API